Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

about

Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

Item

http://www.wikidata.org/entity/Q55405964

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

@en

Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

@nl

type

Item

label

Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

@en

Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

@nl

prefLabel

Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

@en

Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

@nl

P1476

Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

@en

P2093

Ashraf Elsayed Morgan

http://www.w3.org/2001/XMLSchema#string

Elshahat Ibrahem Ismail

http://www.w3.org/2001/XMLSchema#string

Raghda Elsayed Farag

http://www.w3.org/2001/XMLSchema#string

P2860

Selective Inner Hair Cell Dysfunction in Chinchillas Impairs Hearing-in-Noise in the Absence of Outer Hair Cell Loss.

Loudness adaptation accompanying ribbon synapse and auditory nerve disorders.

Side effects of high-dose interferon therapy for chronic hepatitis C.

Epidemiology of hepatitis C virus infection in Pakistan.

The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment.

2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines.

Sofosbuvir (Sovaldi) for the treatment of hepatitis C.

Drug-induced tinnitus and other hearing disorders.

Ototoxicity: the hidden menace.

Evaluation of early hearing damage in personal listening device users using extended high-frequency audiometry and otoacoustic emissions.

P304

10-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JOTO.2017.11.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29937860

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

P932

6002635

http://www.w3.org/2001/XMLSchema#string